BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務情報

MarketLineが発行した調査報告書(DATA904C4471)
◆英語タイトル:BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4471
◆発行会社(リサーチ会社):MarketLine
◆発行日:2018年8月
◆ページ数:52
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,550見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,100見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥55,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or ‘the company’), a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.

Scope

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
BioMarin Pharmaceutical Inc.: Company Overview 9
BioMarin Pharmaceutical Inc.: Overview and Key Facts 9
BioMarin Pharmaceutical Inc.: Overview 9
BioMarin Pharmaceutical Inc.: Key Facts 9
BioMarin Pharmaceutical Inc.: Key Employees 11
BioMarin Pharmaceutical Inc.: Key Employee Biographies 12
BioMarin Pharmaceutical Inc.: Major Products and Services 19
BioMarin Pharmaceutical Inc.: Company History 20
BioMarin Pharmaceutical Inc.: Management Statement 24
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries 26
BioMarin Pharmaceutical Inc.: Key Competitors 27
BioMarin Pharmaceutical Inc.: Company Analysis 28
BioMarin Pharmaceutical Inc.: Business Description 28
BioMarin Pharmaceutical Inc.: SWOT Analysis 30
BioMarin Pharmaceutical Inc.: SWOT Overview 30
BioMarin Pharmaceutical Inc.: Strengths 30
BioMarin Pharmaceutical Inc.: Weaknesses 31
BioMarin Pharmaceutical Inc.: Opportunities 31
BioMarin Pharmaceutical Inc.: Threats 33
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity 35
BioMarin Pharmaceutical Inc.: Financial Deals Overview 35
BioMarin Pharmaceutical Inc.: Targets and Partners 37
BioMarin Pharmaceutical Inc.: Top Deals 2014 – 2018YTD* 38
BioMarin Pharmaceutical Inc.: Advisors 39
BioMarin Pharmaceutical Inc.: Top Legal Advisors 39
BioMarin Pharmaceutical Inc.: Top Financial Advisors 39
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions 40
BioMarin Pharmaceutical Inc.: Capital Raising 41
BioMarin Pharmaceutical Inc.: Partnership 42
BioMarin Pharmaceutical Inc.: Recent Developments 43
BioMarin Pharmaceutical Inc.: News and Events Summary 43
BioMarin Pharmaceutical Inc.: Financial Performance 46
BioMarin Pharmaceutical Inc.: Market Developments 47
BioMarin Pharmaceutical Inc.: Research & Development 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 3: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 8: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 9: BioMarin Pharmaceutical Inc.: Top Deals 2014 - 2018YTD*
Table 10: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 19: BioMarin Pharmaceutical Inc.: Financial Performance
Table 20: BioMarin Pharmaceutical Inc.: Market Developments
Table 21: BioMarin Pharmaceutical Inc.: Research & Development



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務情報(BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆